Adiponectin and cardiovascular risk profile in patients with type 2 diabetes mellitus: Parameters associated with adiponectin complex distribution

Diabetes and Vascular Disease Research

Volumn 8, Issue 3, 2011, Pages 190-194

  Hamilton, Mark P ^a   Gore, M Odette ^a,b   Ayers, Colby R ^b   Wu, Xinyu ^a   McGuire, Darren K ^a,b   Scherer, Philipp E ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Adipokine; Adiponectin isoforms; Biomarker; Cardiovascular disease marker; Metabolic syndrome

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; HIGH MOLECULAR WEIGHT ADIPONECTIN; LOW MOLECULAR WEIGHT ADIPONECTIN; TRIMERIC ADIPONECTIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORRELATION ANALYSIS; DISEASE DURATION; FAST PROTEIN LIQUID CHROMATOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARAMETER; PROTEIN BLOOD LEVEL; QUANTITATIVE ASSAY; RISK ASSESSMENT;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, LIQUID; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TEXAS;

EID: 80052052932     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164111407784     Document Type: Article

References (8)

1. Scherer PE, Williams S, Fogliano M, Baldini G and Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270: 26746-26749.
2. Kusminski CM and Scherer PE. The road from discovery to clinic: adiponectin as a biomarker of metabolic status. Clin Pharmacol Ther 2009; 86: 592-595.
3. Pajvani UB, Du X, Combs TP et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: Implications for metabolic regulation and bioactivity. J Biol Chem 2003; 278: 9073-9085. (Pubitemid 36800387)
4. Pajvani UB, Hawkins M, Combs TP et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione -mediated improvement in insulin sensitivity. J Biol Chem 2004; 279: 12152-12162. (Pubitemid 38445780)
5. Schraw T, Wang ZV, Halberg N, Hawkins M and Scherer PE. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology 2008; 149: 2270-2282. (Pubitemid 351574488)
6. McGuire DK, See R, Abdullah SM et al. The effect of rosiglitazone on integrated cardiovascular performance, cardiac structure, function and myocardial triglyceride: trial design and rationale. Diab Vasc Dis Res 2009; 6: 43-50.
7. Schondorf T, Maiworm A, Emmison N, Forst T and Pfutzner A. Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk. Clin Lab 2005; 51: 489-494. (Pubitemid 41644187)
8. Halberg N, Schraw TD, Wang ZV et al. Systemic fate of the adipocyte-derived factor adiponectin. Diabetes 2009; 58: 1961-1970.